Verified PCD pharma franchise companiesThird party pharma manufacturersTablets · Capsules · Syrups · InjectionsBaddi · Haridwar · Ahmedabad · SikkimLow MOQ for new brandsFree quotes within 24 hoursList your company free
PCD Franchise

Fair MRP and Ethical PCD Pharma Franchise in 2026: Trade Margin Caps, NPPA Pricing and How to Earn at Fair Prices

Why fair MRPs matter for PCD pharma franchise partners in 2026, what the trade margin and solvent rules mean, and how to earn well without inflated prices.

16 min read
Fair MRP and Ethical PCD Pharma Franchise in 2026: Trade Margin Caps, NPPA Pricing and How to Earn at Fair Prices
In this article 10 sections
  1. Why MRPs in the franchise channel are being questioned
  2. Why inflated MRPs are bad business, not just bad optics
  3. What a fair MRP actually looks like
  4. Choosing a PCD company that prices fairly
  5. Ethical promotion is part of fair pricing
  6. The supply side: why quality costs are rising too
  7. Building a franchise that earns well at fair prices
  8. A simple MRP review you can do this week
  9. Frequently Asked Questions
  10. Partner with a PCD Company That Prices Fairly

Every PCD pharma company's price list has two columns that matter: the price the franchise partner pays and the MRP printed on the strip. For years, the gap between the two has been the main selling point of the model. A bigger gap meant a bigger margin, and a bigger margin was what many companies put on the first page of their brochure.

That gap is now under a spotlight. Through 2026, the press, chemist associations and regulators have all paid closer attention to how medicines are priced in the franchise channel, who sets the MRP, and whether patients are paying far more than they need to. For a PCD pharma franchise partner, this is not a reason to panic. It is a reason to look carefully at the MRPs in your bag and ask whether your business would survive a closer look. The partners who build on fair pricing now will be the ones still standing in five years.

This guide explains what has changed, why inflated MRPs are becoming a business risk, how trade margin rules are evolving, and how to build a franchise that earns well without depending on prices patients cannot understand.

Why MRPs in the franchise channel are being questioned

In June 2026, the Free Press Journal published an investigation from Mumbai on what it described as links between some doctors, clinic-attached chemists and PCD companies. The report began with a patient who was sent by a clinic to a nearby chemist for branded generics, then found the same composition elsewhere at around a third of the price. The newspaper said it contacted PCD companies in Chandigarh, Panchkula, Mohali, Ambala, Thane and Nashik, and reported that several offered margins of around 60 per cent, going higher on some products, with monopoly offered on small opening orders.

These are reported allegations, and they do not describe every company or partner in the business. Many franchise companies price fairly and many partners work honestly with doctors and chemists. But the story was widely shared, and health activists quoted in it called for mandatory generic prescribing and disclosure of commercial ties between doctors and distributors. When stories like this travel, regulators and policymakers notice.

The trade margin debate is moving

Policy is moving in the same direction. In October 2026, the government decided to cap trade margins at 30 per cent of MRP on non-scheduled anti-cancer medicines, according to an ANI report carried by Medical Dialogues. Official sources quoted in that report said the move could cut MRPs on these medicines by up to 70 per cent and save an estimated Rs 2,500 crore a year. The All India Organisation of Chemists and Druggists welcomed the decision and argued that MRPs are set upstream by manufacturers, so chemists should not be blamed for them.

That last point matters for franchise partners. If chemists are saying, publicly, that MRP is the manufacturer's responsibility, then the spotlight moves to the companies that set those MRPs and the marketing channels that carry them. In the franchise model, that is the PCD company and its partners.

The cancer drug cap applies to one therapy group. It does not set margins for the general franchise range. But it shows the direction of policy: trade margin rationalisation, which has been discussed for years, is now being applied product group by product group. A partner who depends on very wide margins on non-scheduled products should plan for the possibility that such rules widen over time.

Price control already covers many franchise products

Many of the most common franchise products are already under ceiling prices set by the National Pharmaceutical Pricing Authority. A notification dated 30 April 2026 fixed or revised retail prices of 42 formulations, including pain combinations, antibiotics, cardiac and anti-diabetic drugs and vitamin supplements, according to an ANI report. Overcharging above notified prices can be recovered with interest under DPCO 2013. We covered how this touches pain products in our ortho and pain franchise guide.

Why inflated MRPs are bad business, not just bad optics

It is easy to treat this as a reputation issue. It is more than that. An inflated MRP hurts a franchise partner in at least five practical ways.

Doctors stop prescribing. Patients compare prices on their phones, at the Jan Aushadhi Kendra and at the chemist down the road. When a patient returns to a doctor saying the medicine cost three times what a neighbour paid, the doctor quietly switches brands. You lose the prescription without ever knowing why.

Chemists stop stocking. Chemists deal with patient complaints every day. Many prefer to stock brands they can defend. If your MRP looks out of line, the chemist may still sell it when a prescription demands it, but will not recommend it across the counter or keep extra stock.

Regulatory risk rises. Where a product is under price control, an MRP above the ceiling is an offence, and the recovery comes with interest. Where it is not under control, a very high MRP still invites attention from drug controllers, consumer forums and the press.

Volume stays low. Market data in 2026 show that volume is what separates healthy segments from weak ones. Pharmatrac's August 2026 report, covered by Outlook India, showed value growth of 10.7 per cent in August but volume growth of only about 1 per cent, and chemists' leaders asked for sustainable trade margins, faster inventory turnover and reasonable credit terms. Pharmarack's September numbers showed volume picking up to around 3 per cent, as reported by BioSpectrum India. A partner who wants to ride that volume needs products priced to move.

Your business becomes fragile. A franchise built on a few high-MRP products with huge margins can collapse with one policy change or one bad news story. A franchise built on fairly priced products with steady repeat prescriptions survives both.

What a fair MRP actually looks like

There is no single right MRP for a product. Raw material, dosage form, packaging, freight, GST, the company's overheads and the partner's costs all matter. But there are good ways to judge whether an MRP is reasonable.

Compare with the market, not just the price list

Before you accept a company's MRP, check what the same composition and strength sell for from three or four established brands at your local chemist, and what the Jan Aushadhi equivalent costs. Your MRP does not have to be the lowest. Patients and doctors will pay for a brand they trust. But if your MRP is far above every established brand, you will have to explain why, and you probably cannot. Our guide to Jan Aushadhi Kendras and PCD franchise explains how to position against low-price generics.

Check price control first

For every product, ask the company whether it falls under a ceiling price. If it does, the MRP must be at or below the notified price, plus GST where applicable. Ask the company to show you the NPPA notification it relies on. A serious company will have this ready.

Look at your full cost, not just the gap

Your real margin is not MRP minus purchase price. It is what is left after the chemist's margin, the stockist's margin if you use one, freight, GST effects, samples, your medical representatives' salaries, travel and expiry losses. Many partners discover that a product with a modest headline margin but steady sales earns more than one with a huge gap that sits on shelves. Our article on starting a PCD franchise in 2026 walks through the basic economics.

Think about the patient who pays

The simplest test is this: would you be comfortable if the patient knew what you paid for the product? You do not need to publish your price list. But if the honest answer makes you uneasy, the MRP is probably too high for a lasting business.

Choosing a PCD company that prices fairly

The company you choose decides most of your MRPs, so this is where fair pricing starts. When you compare companies, look beyond the margin percentage on the brochure.

Questions to ask before you sign

Ask how the company sets its MRPs and whether it benchmarks them against the market. Ask which products are under NPPA price control and how it updates MRPs when ceiling prices change. Ask what happens to stock printed with old MRPs after a price revision. Ask for its product list with the composition, strength, pack size, purchase price and MRP side by side, so you can check each line against the market yourself.

Ask too where each product is made. Fair pricing means little if quality is weak. Many franchise companies are based in Chandigarh, Panchkula, Mohali and Ambala and get their products made in Baddi, while others work with plants in Haridwar and Ahmedabad. Ask for manufacturing licence copies, certificates of analysis and the plant's revised Schedule M status, and check the monthly drug alerts on cdsco.gov.in. Our guide on marketer responsibility and NSQ alerts covers this in more depth.

Red flags

Be careful with any company that leads with margin and says little about quality, plant or doctor support. Be careful with very high MRPs on common products like paracetamol, pantoprazole, cetirizine, multivitamins or analgesic combinations, where the market price is well known. Be careful with monopoly offered on a token order with no conditions. It often means the same district has been offered to others. And be careful with any suggestion that the margin is there to be shared with doctors. That is not a business model. It is a liability.

Apromart brings together top companies listed from PAN India, so you can compare several companies' ranges and terms side by side before you decide. Start with the PCD pharma franchise business opportunity listings and narrow down by speciality on speciality-wise PCD pharma companies or by form on dosage-wise PCD pharma companies.

Ethical promotion is part of fair pricing

High MRPs and unethical promotion often go together. When a product has a huge margin, there is pressure to spend part of it on gifts, trips or cash to win prescriptions. The Uniform Code for Pharmaceutical Marketing Practices 2024 restricts these practices, and we explained what is and is not allowed in our article on Revised Schedule M and UCPMP.

A franchise that wins on product quality, availability and regular, informed visits is cheaper to run and safer to own than one that buys prescriptions. It also builds something you can sell or pass on, because doctors prescribe your brand for reasons that will still be true next year.

Practical ethical promotion looks like this: honest detailing with the composition and evidence, samples within the rules, useful clinic materials like dosing charts, continuing medical education that is genuinely educational, and reliable stock at the chemists near every doctor you cover. None of this needs a 90 per cent margin.

The supply side: why quality costs are rising too

Fair pricing has to cover real costs, and those are going up for good reasons. On 3 November 2026, Business Standard reported that CDSCO has directed state and UT drug controllers to require manufacturers and suppliers of specified pharma-grade solvents, including glycerin, propylene glycol, sorbitol, maltitol, polyethylene glycols, polysorbates and ethyl alcohol, to register on the ONDLS portal and obtain a no-objection certificate before distributing each batch. The move follows the 2025 Coldrif cough syrup deaths in Madhya Pradesh linked to diethylene glycol.

Industry voices quoted in the report raised concerns about possible delays if state departments are short-staffed, and said smaller manufacturers could be particularly vulnerable. For franchise partners, the practical effect may be tighter supply or longer lead times on syrups, suspensions and other liquids for a while, and slightly higher costs as plants absorb the extra compliance. That is a fair cost to pay for safer medicines. Plan your winter syrup orders early, and read our guides on paediatric dosage forms and syrup DEG and EG testing for more on this.

The point is that a reasonable MRP is not the cheapest possible MRP. It is one that pays for good manufacturing, proper testing, honest promotion and a fair living for everyone in the chain, without asking the patient to pay several times what the medicine is worth.

Building a franchise that earns well at fair prices

So how does a partner make good money without leaning on inflated MRPs? The answer is the same set of basics that good franchise businesses have always followed, applied with more discipline.

Mix chronic and acute products

Acute products like antibiotics, cough syrups and analgesics bring quick sales but have heavy competition and price pressure. Chronic products for diabetes, heart, thyroid, neuro and long-term supplements bring steady monthly repeats. A balanced bag that adds a cardiac and diabetic range or a neuro-psychiatry range to a general range gives you a base income that does not depend on any single product's margin.

Add speciality products where you have the doctors

Speciality products like derma, gynae and nutrition often carry better margins at fair MRPs, because the formulations are more specific and the doctor's trust matters more than price. Our recent guide to the gynae PCD franchise shows how a speciality range can sit alongside a general bag.

Win on availability

The most underrated profit driver in a franchise is simply being in stock. A doctor who writes your brand and hears from three patients that it was not available will switch. Work closely with stockists, track fast movers weekly and keep a buffer in peak seasons.

Keep the chemist on your side

Chemists are under pressure from e-pharmacies, price comparisons and rising costs, and their associations have been asking for sustainable margins and reasonable credit. A franchise partner who gives chemists fair margins, reliable supply, honest pricing and quick expiry returns becomes a supplier they value. We looked at the changing retail landscape in our article on e-pharmacies and the chemists' strike.

Choose your territory carefully

A territory you can cover well, with a monopoly agreement in writing, protects your prescriptions from being undercut by another partner selling the same brand at a lower price. Our guide on PCD territory planning and monopoly rights explains how to size and protect a territory.

A simple MRP review you can do this week

Take your current product list and, for each product, write down four numbers: your purchase price, your MRP, the MRP of the leading brand of the same composition and strength, and the Jan Aushadhi price if there is one. Then mark each product green, amber or red.

Green products are priced within a reasonable range of established brands. Keep pushing them. Amber products are noticeably above the market but have some reason, such as a better formulation or pack. Be ready to explain the difference to doctors. Red products are far above every comparable brand with no real reason. Talk to your company about repricing them, or replace them with fairly priced alternatives.

Also check every product against NPPA ceiling prices. Any product above its ceiling must be fixed immediately. The review takes a few hours and usually shows that a handful of red products carry more risk than they are worth.

Many partners who do this exercise find that their best-earning products were never the ones with the widest margin. They were the ones doctors kept writing month after month because the patient never complained. That is the business worth building.

Frequently Asked Questions

Who decides the MRP in a PCD pharma franchise?

The MRP is set by the company that markets the product, within NPPA ceiling prices where a product is under price control. Chemist associations have publicly said MRPs are set upstream by manufacturers, so franchise partners should review the MRPs on every product they take and push back on any that look unreasonable.

Is a high margin always good for a franchise partner?

No. A very wide gap between purchase price and MRP can mean the MRP is far above the market, which leads to fewer prescriptions, less chemist support and higher regulatory risk. Steady sales at a fair MRP usually earn more over time than a high margin on products that do not move.

What did the government decide on trade margins in October 2026?

According to an ANI report, the government decided to cap trade margins at 30 per cent of MRP on non-scheduled anti-cancer medicines, which official sources said could cut MRPs by up to 70 per cent and save about Rs 2,500 crore a year. The All India Organisation of Chemists and Druggists welcomed the move.

Does the trade margin cap apply to my general PCD range?

The October 2026 cap applies to non-scheduled anti-cancer medicines, not to general franchise products. However, many common franchise products are already under NPPA ceiling prices, and the trend toward trade margin rationalisation suggests partners should not depend on extremely wide margins.

How do I check whether a product's MRP is fair?

Compare it with three or four established brands of the same composition and strength at local chemists and with the Jan Aushadhi price. Check whether it falls under an NPPA ceiling price. If your MRP is far above every comparable brand without a clear reason, ask your company to review it.

What is the CDSCO solvent order and how does it affect franchise partners?

As reported on 3 November 2026, CDSCO has asked state drug controllers to require suppliers of pharma-grade solvents such as glycerin, propylene glycol and sorbitol to register on ONDLS and get an NOC before distributing each batch. Franchise partners may see longer lead times or slightly higher costs on syrups and liquids, so it is wise to place winter orders early.

What are the red flags when choosing a PCD company?

Watch for companies that lead only with margin, very high MRPs on common molecules, monopoly offered on a token order without conditions, little information about the manufacturing plant, and any suggestion that margins are meant to be shared with doctors.

How can I build a profitable franchise without inflated MRPs?

Balance chronic and acute products, add speciality ranges where you have doctors, stay in stock, treat chemists fairly, choose a territory you can cover with a written monopoly, and promote ethically. These basics create repeat prescriptions that earn well at fair prices.

Partner with a PCD Company That Prices Fairly

If you are reviewing your current range or looking for a new franchise company, Apromart can help you compare companies on range, pricing, quality and terms before you commit. Browse PCD pharma franchise companies, then post your requirement with your district and the specialities you cover, and verified companies will contact you. If you would like a second opinion on a company's terms, contact the Apromart team.

Found this useful? Share it
Keep reading

Related articles

All articles →

Latest from the blog

Ready to start your pharma franchise journey?

Post one requirement and get quotes from verified PCD franchise companies and third-party manufacturers — free.

Call +91 98772 38195 WhatsApp Now

Post your requirement

Get quotes from verified pharma companies — free.

I'm looking for
GST number?
Drug licence?
Your number is shared only with matching companies.